Lv31
228 积分 2022-10-28 加入
Enhancements in Parkinson's Disease Management: Leveraging Levodopa Optimization and Surgical Breakthroughs
1小时前
待确认
G-protein coupled receptor 6 deficiency alters striatal dopamine and cAMP concentrations and reduces dyskinesia in a mouse model of Parkinson's disease
3天前
已完结
First-Time Disclosure of CVN424, a Potent and Selective GPR6 Inverse Agonist for the Treatment of Parkinson’s Disease: Discovery, Pharmacological Validation, and Identification of a Clinical Candidate
3天前
已完结
Pharmacokinetics and disposition of anlotinib, an oral tyrosine kinase inhibitor, in experimental animal species
6天前
已完结
Induction of Trop-2 expression through the binding of galectin-3 to MUC1
26天前
已完结
PankoMab: a potent new generation anti-tumour MUC1 antibody
26天前
已完结
Surfaceome Profiling Suggests Potential of Anti-MUC1×EGFR Bispecific Antibody for Breast Cancer Targeted Therapy
26天前
已完结
Galectin-3 regulates MUC1 and EGFR cellular distribution and EGFR downstream pathways in pancreatic cancer cells
26天前
已完结
Combination of Lurbinectedin plus Irinotecan: Preclinical and Early Clinical Results in Relapsed Small Cell Lung Cancer Patients
1个月前
已完结
Discovery of an Orally Bioavailable and Selective PKMYT1 Inhibitor, RP-6306
1个月前
已完结
皖公网安备34019202002308